TuHURA Biosciences Inc. (NASDAQ: HURA) filed a prospectus supplement on Wednesday detailing an at-the-market offering agreement with H.C. Wainwright & Co., LLC dated November 3, 2025.

Under the sales agreement, TuHURA may offer and sell shares of its common stock with an aggregate offering price of up to $50 million from time to time through H.C. Wainwright, which will act as sales agent and/or principal in the transactions.

The shares carry a par value of $0.001 per share. The company will determine the timing and volume of sales under the agreement based on market conditions and its capital needs.

At-the-market offerings allow companies to sell shares directly into the existing trading market at prevailing market prices, providing flexibility in raising capital without the traditional underwriting process of a secondary offering.